Background A systematic review in 2019 found reductions in antimicrobial resistance (AMR)
of pneumococcal vaccine serotypes following pneumococcal conjugate vaccine (PCV) …

We describe the impact of non-pharmaceutical interventions (NPIs) during the COVID-19
pandemic on invasive pneumococcal disease (IPD) in Calgary. IPD declined significantly …

The aim of this study was to investigate the serotype-associated fatality rate in cases of
invasive pneumococcal disease (IPD) in the Spanish region of Madrid between 2007 and …

We describe the effects of the 7-valent (PCV7) and 13-valent (PCV13) pneumococcal
conjugate vaccines on pneumococcal meningitis in England and Wales during July 1, 2000 …

Background Pneumococcal conjugate vaccine (PCV) implementation has led to a sharp
decrease in invasive pneumococcal disease (IPD) due to the reduction in PCV serotypes …

Introduction: With the use of pneumococcal conjugate vaccines (PCV), the behavior of
invasive pneumococcal disease (IPD) has changed relative to serotype distribution. The …

Objective This study was performed to analyze the serotype distribution of Streptococcus
pneumoniae causing invasive pneumococcal disease (IPD) in children aged 5 years and …

Background: Routine rotavirus (RV)-vaccination is recommended in Germany since August
2013. Five years later, we evaluated the recommendation by examining vaccine uptake and …

Vaccinations against Streptococcus pneumoniae are included in infant immunization
programs globally. However, a substantial burden due to pneumococcal disease (PD) …

Background Reports on the effectiveness of pneumococcal conjugate vaccines (PCVs) on
pediatric parapneumonic effusion are limited. We report the changes in cases and etiologies …